Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Opinion in Nephrology and Hypertension|January 27, 1998
The renal monoamine oxidases: pathophysiology and targets for therapeutic interventionN Pizzinat, A Remaury, A Parini
The Journal of Biological Chemistry|March 30, 2001
Identification of a truncated form of the G-protein regulator AGS3 in heart that lacks the tetratricopeptide repeat domainsN Pizzinat, A Takesono, S M Lanier
Molecular Pharmacology|April 1, 1997
Predominant expression of monoamine oxidase B isoform in rabbit renal proximal tubule: regulation by I2 imidazoline ligands in intact cellsC Gargalidis-Moudanos, A Remaury, N Pizzinat, et al.
Contraception, Fertilite, Sexualite (1992)|March 1, 1995
[Differential effect of estrogens in target tissues]P Barraille, N Pizzinat, F Bayard, et al.
Trends in Pharmacological Sciences|January 1, 1996
The elusive family of imidazoline binding sitesA Parini, C G Moudanos, N Pizzinat, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 25, 1999
Reactive oxygen species production by monoamine oxidases in intact cellsN Pizzinat, N Copin, C Vindis, et al.
Kidney International|October 3, 1999
Serotonin metabolism in rat mesangial cells: involvement of a serotonin transporter and monoamine oxidase AN Pizzinat, J P Girolami, A Parini, et al.
Neurochemistry International|January 1, 1997
I2-imidazoline binding sites and monoamine oxidase activity in human postmortem brain from patients with Parkinson's diseaseC Gargalidis-Moudanos, N Pizzinat, F Javoy-Agid, et al.
Life Sciences|July 27, 1999
Characterization of monoamine oxidase isoforms in human islets of LangerhansN Pizzinat, S L Chan, A Remaury, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 23, 2009
Dose-dependent activation of distinct hypertrophic pathways by serotonin in cardiac cellsC Villeneuve, A Caudrillier, C Ordener, et al.
Pageof 2